Valuation: GI Innovation, Inc.

Market Cap 478B 333M 289M 269M 247M 467M 31.75B 474M 3.17B 1.24B 15.81B 1.25B 1.22B 53B P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 443B 309M 268M 250M 229M 433M 29.45B 440M 2.94B 1.15B 14.66B 1.16B 1.13B 49.16B EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.28%
Yield 2024 *
-
Yield 2025 -
1 day+8.65%
1 week-1.72%
1 month-28.27%
3 months-54.40%
6 months-53.13%
Current year-57.99%
1 week 6,470
Extreme 6470
8,220
1 month 6,470
Extreme 6470
9,980
Current year 6,470
Extreme 6470
18,830
1 year 6,470
Extreme 6470
21,000
3 years 6,470
Extreme 6470
24,900
5 years 6,470
Extreme 6470
24,900
10 years 6,470
Extreme 6470
24,900
Manager TitleAgeSince
Chief Executive Officer 58 01/07/2025
Chief Executive Officer 54 15/06/2021
Director of Finance/CFO - 31/08/2024
Director TitleAgeSince
Director/Board Member 54 15/06/2021
Director/Board Member 58 30/06/2017
Director/Board Member 64 28/02/2022
Date Insider Type Main position Quantity % Market Cap.
20/01/26 Expiration 14 0.0000%
20/01/26 Fiscal year

Chief Technology Officer

445 0.0007%
20/01/26 Fiscal year 14 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+8.65%-1.72%-60.63%-29.12% 333M
-1.40%+2.59%-1.71%+11.28% 48.53B
-2.41%-0.90%+403.17%+614.40% 39.87B
-1.16%+12.96%+26.45%+5.03% 38.68B
-1.88%-3.03%+4.94%+47.52% 35.13B
-1.74%+5.12%+9.58%+46.02% 29.79B
-2.85%-3.92% - - 16.08B
-0.21%-4.04%+35.09%+127.95% 16.11B
-0.64%+2.65%+1.25%+8.92% 13.61B
-1.19%-1.32%-3.32%-34.94% 12.62B
Average -0.48%+0.23%+46.09%+88.56% 25.08B
Weighted average by Cap. -1.58%+2.02%+76.67%+127.88%

Financials

2024 2025
Net sales 24.28M 16.89K 14.69K 13.67K 12.55K 23.7K 1.61M 24.07K 161K 63.23K 803K 63.44K 62.05K 2.69M 5.84B 4.06M 3.53M 3.29M 3.02M 5.7M 388M 5.79M 38.74M 15.2M 193M 15.25M 14.92M 647M
Net income -58.78B -40.9M -35.55M -33.09M -30.38M -57.37M -3.9B -58.26M -390M -153M -1.94B -154M -150M -6.52B -35.13B -24.44M -21.25M -19.78M -18.16M -34.29M -2.33B -34.82M -233M -91.5M -1.16B -91.8M -89.79M -3.9B
Net Debt -3.44B -2.39M -2.08M -1.94M -1.78M -3.36M -228M -3.41M -22.82M -8.96M -114M -8.99M -8.79M -381M -34.63B -24.09M -20.94M -19.49M -17.9M -33.8M -2.3B -34.32M -230M -90.18M -1.14B -90.48M -88.49M -3.84B
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
31/07/26 ₩7,410.00 +8.65% 495,046
30/07/26 ₩6,820.00 -2.15% 323,099
29/07/26 ₩6,970.00 -8.53% 861,993
28/07/26 ₩7,620.00 -4.51% 312,815
27/07/26 ₩7,980.00 +5.84% 345,241
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock